Lipitor Weathers Crestor Launch; Lancet Weighs In On Pfizer’s Side
Executive Summary
The early returns in the Lipitor versus Crestor marketing battle are running heavily in favor of Pfizer
You may also be interested in...
Crestor Has 4.6% New Rx Share; DTC Campaign To Launch In March
AstraZeneca's Crestor accounts for 4.6% of new statin prescriptions, the company said
Crestor Has 4.6% New Rx Share; DTC Campaign To Launch In March
AstraZeneca's Crestor accounts for 4.6% of new statin prescriptions, the company said
Pfizer Launches Inspra; Will Help Company Reach $54 Bil. In 2004
Pfizer is beginning its launch of the congestive heart failure therapy Inspra